The August 2024 Medicaid Preferred Drug List (PDL) is now available. This latest update includes significant changes approved during the January and April 2024 Drug Utilization Review Board meetings. These updates impact formulary details, prior authorization requirements, and include specific notations for drugs requiring clinical prior authorization.
The updated PDL also features appendices for certain drug categories, such as cough and cold products, iron oral agents, and prenatal vitamins. It’s crucial to review these changes to ensure you have the most current information when prescribing medications for your patients.
To access the full list of updates and explore key resources such as the Preferred Drug List Criteria Guide, Non-preferred Prior Authorization Information, and more, please visit the Health and Human Services link below.
Stay informed and ensure compliance with the latest PDL changes by reading more here.
Providers are encouraged to share this information with their staff. If you have any questions about this notice, please email Provider Relations at ProviderRelations@cfhp.com or call 210-358-6294. You can also contact your Provider Relations Representative directly.
To access all Provider alerts:
- Log into the Community First Provider Portal
- Go to CommunityFirstHealthPlans.com/Provider-News
- Sign up for the Community First Provider e-Newsletter